We are happy to announce the launch of an informative website about clinical trials by another of our supporting partners. F. Hoffmann-La Roche Ltd. has put together a website called ForPatients, which includes a search tool for finding clinical trials in various cancer indications, plus...
Join us for this free webinar, which reviews the latest news and clinical data related to melanoma treatment in the adjuvant setting, as presented in the 2018 conference season. 'Adjuvant' refers to patients with a stage II or stage III diagnosis. The majority of adjuvant patients typically undergo...
On September 26, 2018, you may have seen a special insert in the paper version of the National Post across the country, featuring eight pages of informative articles about immunotherapy, an innovative treatment proving successful in several cancer indications. This special content is the result...
In September 2018, Save Your Skin Foundation (SYSF) conducted an anonymous survey of melanoma patients in the adjuvant setting (diagnosed at a stage lesser than stage IV). This survey, titled "Melanoma Treatments in the Adjuvant Setting," was open globally, and we received responses from all...
We are excited to announce that one of our partners, Merck, has launched an informative new website dedicated to educating the public about immuno-oncology. “Redefining Cancer Treatment” is an apt title for the topic: what is cancer immunotherapy, and how does it work, exactly? These questions...
In advance of the upcoming Drug Pricing Policy Summit in Toronto in November, you are invited to join the webinar: Health Care Systems in Canada: Where We Are Now on Wednesday, October 24th from 12:00 - 1:00 PM ET. This webinar will provide a broad overview...
Last weekend I went for a 15 kilometre walk— as in, 15 kilometres all at once. Two short years ago I could not have done that, being in recovery from surgeries and treatment for advanced melanoma, I was not physically or psychologically capable of such...
Save Your Skin has the opportunity to submit patient feedback to the pCODR process for the two treatments coming to the Adjuvant setting for Melanoma patients in Canada. To learn more about the drug approval process and our involvement as a patient representation group, please...
Please participate in this survey regarding preferences for adjuvant treatment of melanoma in Canada. The ANONYMOUS SURVEY will require approximately 30 minutes to complete. Sponsored by Novartis, the information in this study may be included in research publications and submissions to agencies that evaluate and make...
Can you help to shape the future of cancer care? Check out this patient survey launched in Canada. In healthcare, inefficiency is often caused by neglecting to focus on what matters most to patients. A new international patient survey is gathering insights on inefficiencies in cancer care and...
